PubMed · 1985 · 42 citations · 15 references
MedicineImmunologyPathologyAutoimmunityImmunopathologyInflammationChronic InflammationCytokine-mediated PathologyImmune-mediated Inflammatory DiseasesInflammatory Cell ResponsesInflammatory SignalingSystemic SclerosisCollagen Type I DepositionDisease DurationFibroblast ActivationFibrosis In Systemic SclerosisSkin FibrosisT Cell-mediated InflammationT-cell Mediated InflammationType I Collagen Deposition
Interleukin-1 (IL-1) is a monocyte derived factor that participates in immune regulation and in the regulation of fibroblast proliferation and collagen deposition. It therefore, seems particularly pertinent to study in scleroderma, a disorder of immune regulation where increased collagen deposition is a hallmark. The production of IL-1 by lipopolysaccharide stimulated monocytes from 18 untreated scleroderma patients was akin to that of their normal matched controls. However, the unstimulated monocytes from six of the 18 scleroderma patients released IL-1 activity spontaneously into their supernatants. All six patients with spontaneous IL-1 release had less than 5 years disease duration. The response to IL-1 by T lymphocytes from patients with scleroderma was low as compared to those from controls. The presence of spontaneous IL-1 production with decreased response to IL-1 in scleroderma may indicate an in vivo pre-activation of monocytes to produce this factor that might have a bearing in the pathogenesis of collagen deposition in scleroderma.
15
Interleukin 1, a potential regulator of fibroblast proliferation.
John A. Schmidt, S B Mizel, Donald A. Cohen et al. · The Journal of Immunology · 1982 · 834 citations
The functional relationship of the interleukins.
Kevin M. Smith, Lawrence B. Lachman, Joost J. Oppenheim et al. · The Journal of Experimental Medicine · 1980 · 654 citations · Full text
S B Mizel, J M Dayer, S. M. Krane et al. · Proceedings of the National Academy of Sciences · 1981 · 614 citations · Full text